The therapeutic value of acupoint sensitization for patients with adhesive capsulitis (frozen shoulder)

ISRCTN ISRCTN77430077
DOI https://doi.org/10.1186/ISRCTN77430077
Submission date
29/11/2023
Registration date
13/12/2023
Last edited
11/12/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Recent studies have confirmed the phenomenon of acupoint sensitization in patients with frozen shoulder. However, the curative effect of acupuncture on patients with frozen shoulder with different degrees of acupoint sensitization is unclear. Therefore, the aim of this study is to explore the clinical effectiveness of acupoint sensitization points in patients with frozen shoulder.

Who can participate?
Patients aged 18 to 75 years with frozen shoulder with a definite diagnosis and a disease course of more than 6 weeks

What does the study involve?
Patients will be divided into a high-sensitivity group and a low-sensitivity group. Both groups were given basic treatment measures to guide shoulder joint functional exercise. In addition, according to the results of the pressure-pain sensitivities exploration, acupuncture treatment was given to the five points with the highest percentage of pressure pain thresholds reduction in patients in the high-sensitivity group and acupuncture treatment was given to the five points with the lowest percentage of pressure pain thresholds reduction in patients in the low-sensitivity group. The exploration of acupoint pressure-pain sensitivities was determined by a trained doctor of traditional Chinese medicine who was not involved in the study and knew the specific group of patients. After the ranking of acupoint pressure-pain sensitivities is determined, the doctor mentioned above will inform the therapist of the acupuncture points that need to be applied, but not mention the pressure-pain sensitivities degree of the acupuncture points that need to be treated.

What are the possible benefits and risks of participating?
The benefit of this research is that it could relieve patients' pain. Acupuncture therapy rarely causes adverse reactions, and the rare adverse reactions are local skin adverse reactions, including subcutaneous bleeding or local skin allergy.

Where is the study run from?
Luoyang Orthopedic Hospital of Henan Province (China)

When is the study starting and how long is it expected to run for?
March 2023 to February 2024

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Ms Qiuyuan Wang, 1010707935@qq.com

Contact information

Ms Qiuyuan Wang
Public, Scientific, Principal Investigator

NO. 82 Qiming South Road
Luoyang
471000
China

ORCiD logoORCID ID 0000-0003-0903-2917
Phone +86 (0)18003797673
Email 1010707935@qq.com

Study information

Study designRandomized double-blind positive-controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeEfficacy
Participant information sheet 44662_CRF.pdf
Scientific titleAcupuncture for adhesive capsulitis (frozen shoulder) with sensitive acupoints: a randomized controlled trial
Study objectivesThe curative effect of acupuncture at acupoints with high sensitivity is better than that at acupoints with low sensitivity in the treatment of frozen shoulder.
Ethics approval(s)

Approved 07/11/2023, Ethics Committee of Luoyang Orthopedic Hospital of Henan Province (Orthopedic Hospital of Henan Province, No. 82 Qiming South Road, Luoyang, 471000, China; +86 (0)379 63546181; lyzgll@sina.com), ref: 2023ZXKT0007-01

Health condition(s) or problem(s) studiedAcupuncture at acupoints with different pressure-pain sensitivities for adhesive capsulitis (frozen shoulder)
InterventionRandomization: A researcher who is not involved in subsequent studies will use computer-generated random sequences which are put in a sealed envelope for random grouping.

Patients will be divided into a high-sensitivity group and a low-sensitivity group. Both groups were given basic treatment measures to guide shoulder joint functional exercise. In addition, according to the results of the pressure-pain sensitivities exploration, acupuncture treatment was given to the five points with the highest percentage of pressure pain thresholds reduction in patients in the high-sensitivity group and acupuncture treatment was given to the five points with the lowest percentage of pressure pain thresholds reduction in patients in the low-sensitivity group. The exploration of acupoint pressure-pain sensitivities was determined by a trained doctor of traditional Chinese medicine who was not involved in the study and knew the specific group of patients. After the ranking of acupoint pressure-pain sensitivities is determined, the doctor mentioned above will inform the therapist of the acupuncture points that need to be applied, but not mention the pressure-pain sensitivities degree of the acupuncture points that need to be treated.

Acupuncture operation method: A specialized therapist will help the patient select a suitable position, use iodopol for routine disinfection of local skin, and then insert a disposable sterile acupuncture needle (Huatao brand, 0.30 mm × 25 mm) into the acupoint, and lift and twist the needle after the patient feels the acid swelling. Each treatment lasted 30 minutes, once a day. A treatment diary is used to monitor and evaluate the course of treatment.
Intervention typeSupplement
Primary outcome measureThe following primary outcome measures are assessed at baseline, the end of treatment, 4, and 8 weeks after the end of treatment:
1. Pain is measured using a visual analogue scale (VAS)
2. Shoulder joint function is measured using the motion of the shoulder joint in all directions
3. Shoulder joint function is measured using a Shoulder Pain and Disability Index (SPADI)
Secondary outcome measures1. Acupoint sensitization is measured using pressure pain thresholds at baseline, the end of treatment, 4, and 8 weeks after the end of treatment
2. Shoulder joint function is measured using rotator cuff quality of life (RC-QoL) at baseline, the end of treatment, 4, and 8 weeks after the end of treatment.
3. The incidence of possible complications related to acupuncture is measured using a record on the participant information sheet after treatment.
Overall study start date10/03/2023
Completion date10/02/2024

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit75 Years
SexBoth
Target number of participants160
Key inclusion criteriaPatients with frozen shoulder with definite diagnosis and disease course of more than 6 weeks
Key exclusion criteria1. Patients with severe pain at rest (VAS score over 70 mm)
2. The affected shoulder has more than 50% limited motion during two or more exercises compared to the healthy shoulder
3. Patients with other shoulder diseases (such as rotator cuff injury), previous shoulder surgery, or major injury history
4. Patients with cervical spine disease
5. History of anti-inflammatory drug use within 2 weeks before clinical trial, and history of intra-articular steroid injection within 3 months
6. Taking medication for mental illness
7. Have fainted during acupuncture treatment
Date of first enrolment01/12/2023
Date of final enrolment05/02/2024

Locations

Countries of recruitment

  • China

Study participating centre

Luoyang Orthopedic Hospital of Henan Province
Department of Orthopedic Surgery
No. 82 Qiming South Road
Luoyang City
471000
China

Sponsor information

Luoyang Orthopedic-Traumatological Hospital of Henan Province
Hospital/treatment centre

No. 82 Qiming South Road
Luoyang City
471000
China

Phone +86 (0)379 63546550
Email zgyy6354@sina.com
Website http://www.lyzhenggu.cn/
ROR logo "ROR" https://ror.org/05br7cm44

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date01/06/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets generated during and/or analyzed during the current study will be available upon request from Ms Qiuyuan Wang (1010707935@qq.com). Consent will be obtained from participants to share anonymized data. This will be made available subject to a data-sharing agreement. Data will only be shared after there is an appropriate agreement in place and anonymized prior to sharing.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version Case report form and study outcome measure forms 11/12/2023 No Yes

Additional files

44662_CRF.pdf

Editorial Notes

11/12/2023: Study's existence confirmed by the Ethics Committee of Luoyang Orthopedic Hospital of Henan Province (Henan Orthopedic Hospital) (China).